A combination of gliclazide and metformin attenuates obesity-induced polycystic ovary syndrome in female Wistar rats.

These results were considered moderately significant when p < 0.01 and highly significant when p < 0.0001. 3 Results 3.1 Effect on body weight There was an insignificant difference in body weight in all groups in contrast to normal control before administering HFD.

also in 2,182 other papers